U.S. markets closed

Y-mAbs Therapeutics, Inc. (YMAB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
31.37-2.83 (-8.27%)
At close: 4:00PM EDT

31.37 0.00 (0.00%)
After hours: 4:22PM EDT

Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Total Revenue
26,133
20,750
0
0
0
Cost of Revenue
2,296
2,203
-
-
-
Gross Profit
23,837
18,547
-
-
-
Operating Expense
145,284
138,482
83,004
43,230
19,244
Operating Income
-121,447
-119,935
-83,004
-43,230
-19,244
Net Non Operating Interest Income Expense
-308
598
1,976
-44
-
Other Income Expense
-
-2,203
-
-44
83
Pretax Income
-59,745
-119,337
-81,028
-43,274
-19,161
Net Income Common Stockholders
-59,745
-119,337
-81,028
-43,274
-19,161
Diluted NI Available to Com Stockholders
-59,745
-119,337
-81,028
-43,274
-19,161
Basic EPS
-
-
-2.30
-1.50
-0.58
Diluted EPS
-
-
-2.30
-1.50
-0.58
Basic Average Shares
-
-
35,183
28,772
33,294
Diluted Average Shares
-
-
35,183
28,772
33,294
Total Operating Income as Reported
-121,447
-119,935
-83,004
-43,230
-19,244
Total Expenses
147,580
140,685
83,004
43,230
19,244
Net Income from Continuing & Discontinued Operation
-59,745
-119,337
-81,028
-43,274
-19,161
Normalized Income
-59,745
-119,337
-81,028
-43,274
-19,161
Interest Income
-
598
1,976
-
-
Net Interest Income
-308
598
1,976
-44
-
EBIT
-59,437
-119,935
-83,004
-43,230
-19,244
EBITDA
-58,997
-
-
-
-
Reconciled Cost of Revenue
2,296
2,203
-
-
-
Reconciled Depreciation
440
396
166
29
0
Net Income from Continuing Operation Net Minority Interest
-59,745
-119,337
-81,028
-43,274
-19,161
Normalized EBITDA
-58,997
-119,539
-82,838
-43,201
-19,244
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0